Greater access to clinical trial data with the ability to aggregate information for meta-analyses increases the likelihood of identifying new medical breakthroughs and decreases the time to market for effective, safe treatments. However, data transparency and data sharing initiatives still face significant challenges both in creation and execution.
Why read this paper?
This complimentary paper provides additional details and highlights:
- Case studies from organizations that have been successful, including the GlaxoSmithKline data transparency initiative and the Project Data Sphere data sharing initiative.
- Nine steps for a data sharing breakthrough to occur.
- Ways to best support or participate in this evolution of clinical research.